Jennifer A. Rabbitts
Research Subjects
Research Interests
Jennifer A. Rabbitts has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Carmen Morales
Unit of Organizational Quality in the School of Midwifery and Nursing of the San Martin de Porres University, Lima, Peru
1 shared publicationCornelius B. Groenewald
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
1 shared publicationEmma Hart
1 shared publicationJ. R. Sawyer
1 shared publicationJukka Räsänen
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
1 shared publicationN. A. Strom
1 shared publication
Latest Publications
- 22 November 2010
- Published by Wiley in Pediatric Anesthesia
- Vol. 20 (12) , 1078-1083
Perioperative opioid requirements are decreased in hypoxic children living at altitude
To investigate the effect of altitude on perioperative opioid requirements in otherwise healthy children. To investigate whether children living and having surgery at high altitude received different doses of fentanyl than those living and having surgery at sea level. Recent studies in animals (Anesthesiology, 105, 2006 and 715) and children with obstructive sleep apnea (Anesthesiology, 105, 2006 and 665; Anesthesiology 100, 2004 and 806) suggest that analgesic effects of exogenous opioids are enhanced by hypoxia. However, the effects of hypoxia on perioperative narcotic requirements in otherwise healthy children have not been previously reported. We reviewed retrospectively the opioid requirements of pediatric patients who underwent cleft lip or palate surgery during Smile Network International mission trips to Cusco and Lima, Peru between 2007 and 2009. Patients who had surgery at high altitude were compared to those who had surgery at sea level. All patients received a standardized anesthetic with intravenous fentanyl as the only perioperative opioid. Hundred and two patients had surgery at 3399 m above sea level (masl) (Cusco) and 169 patients had surgery at 150 masl (Lima). Patients at high altitude had significantly lower baseline oxygen saturations (92 ± 4% vs 98 ± 3%; P < 0.001) and received 40% less opioid (1.2 ± 0.8 vs 2.0 ± 1.4 μg·kg(-1) per h; P < 0.001) compared to patients at sea level. Opioid administration was reduced in otherwise healthy children with altitude-induced chronic hypoxia when compared to non-hypoxic children undergoing similar operations under similar anesthetic regimens. Whether this difference is due to altitude or altitude-induced hypoxia, requires further study.
- 22 November 2010
- Published by Wiley in Pediatric Anesthesia
- Vol. 20 (12) , 1078-1083
Perioperative opioid requirements are decreased in hypoxic children living at altitude
To investigate the effect of altitude on perioperative opioid requirements in otherwise healthy children. To investigate whether children living and having surgery at high altitude received different doses of fentanyl than those living and having surgery at sea level. Recent studies in animals (Anesthesiology, 105, 2006 and 715) and children with obstructive sleep apnea (Anesthesiology, 105, 2006 and 665; Anesthesiology 100, 2004 and 806) suggest that analgesic effects of exogenous opioids are enhanced by hypoxia. However, the effects of hypoxia on perioperative narcotic requirements in otherwise healthy children have not been previously reported. We reviewed retrospectively the opioid requirements of pediatric patients who underwent cleft lip or palate surgery during Smile Network International mission trips to Cusco and Lima, Peru between 2007 and 2009. Patients who had surgery at high altitude were compared to those who had surgery at sea level. All patients received a standardized anesthetic with intravenous fentanyl as the only perioperative opioid. Hundred and two patients had surgery at 3399 m above sea level (masl) (Cusco) and 169 patients had surgery at 150 masl (Lima). Patients at high altitude had significantly lower baseline oxygen saturations (92 ± 4% vs 98 ± 3%; P < 0.001) and received 40% less opioid (1.2 ± 0.8 vs 2.0 ± 1.4 μg·kg(-1) per h; P < 0.001) compared to patients at sea level. Opioid administration was reduced in otherwise healthy children with altitude-induced chronic hypoxia when compared to non-hypoxic children undergoing similar operations under similar anesthetic regimens. Whether this difference is due to altitude or altitude-induced hypoxia, requires further study.
- 10 November 2009
- Published by Wiley in The Journal of Physiology
- Vol. 587 (22) , 5441-5449
Influence of endogenous angiotensin II on control of sympathetic nerve activity in human dehydration
Arterial blood pressure can often fall too low during dehydration, leading to an increased incidence of orthostatic hypotension and syncope. Systemic sympathoexcitation and increases in volume regulatory hormones such as angiotensin II (AngII) may help to maintain arterial pressure in the face of decreased plasma volume. Our goals in the present study were to quantify muscle sympathetic nerve activity (MSNA) during dehydration (DEH), and to test the hypothesis that endogenous increases in AngII in DEH have a mechanistic role in DEH‐associated sympathoexcitation. We studied 17 subjects on two separate study days: DEH induced by 24 h fluid restriction and a euhydrated (EUH) control day. MSNA was measured by microneurography at the peroneal nerve, and arterial blood pressure, electrocardiogram, and central venous pressure were also recorded continuously. Sequential nitroprusside and phenylephrine (modified Oxford test) were used to evaluate baroreflex control of MSNA. Losartan (angiotensin type 1 receptor (AT1) antagonist) was then administered and measurements were repeated. MSNA was elevated during DEH (42 ± 5 vs. EUH: 32 ± 4 bursts per 100 heartbeats, P= 0.02). Blockade of AT1 receptors partially reversed this change in MSNA during DEH while having no effect in the control EUH condition. The sensitivity of baroreflex control of MSNA was unchanged during DEH compared to EUH. We conclude that endogenous increases in AngII during DEH contribute to DEH‐associated sympathoexcitation.
- 10 November 2009
- Published by Wiley in The Journal of Physiology
- Vol. 587 (22) , 5441-5449
Influence of endogenous angiotensin II on control of sympathetic nerve activity in human dehydration
Arterial blood pressure can often fall too low during dehydration, leading to an increased incidence of orthostatic hypotension and syncope. Systemic sympathoexcitation and increases in volume regulatory hormones such as angiotensin II (AngII) may help to maintain arterial pressure in the face of decreased plasma volume. Our goals in the present study were to quantify muscle sympathetic nerve activity (MSNA) during dehydration (DEH), and to test the hypothesis that endogenous increases in AngII in DEH have a mechanistic role in DEH‐associated sympathoexcitation. We studied 17 subjects on two separate study days: DEH induced by 24 h fluid restriction and a euhydrated (EUH) control day. MSNA was measured by microneurography at the peroneal nerve, and arterial blood pressure, electrocardiogram, and central venous pressure were also recorded continuously. Sequential nitroprusside and phenylephrine (modified Oxford test) were used to evaluate baroreflex control of MSNA. Losartan (angiotensin type 1 receptor (AT1) antagonist) was then administered and measurements were repeated. MSNA was elevated during DEH (42 ± 5 vs. EUH: 32 ± 4 bursts per 100 heartbeats, P= 0.02). Blockade of AT1 receptors partially reversed this change in MSNA during DEH while having no effect in the control EUH condition. The sensitivity of baroreflex control of MSNA was unchanged during DEH compared to EUH. We conclude that endogenous increases in AngII during DEH contribute to DEH‐associated sympathoexcitation.
- 1 May 2009
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 41 (5) , 76
Influences Of Dehydration On The Sympathetic Nervous System In Humans: Role Of Angiotensin
- 1 May 2009
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 41 (5) , 76
Influences Of Dehydration On The Sympathetic Nervous System In Humans: Role Of Angiotensin